What is Alto Neuroscience's other assets?

Alto Neuroscience (ANRO) reported other assets of $338K in Q1 2026.

How has Alto Neuroscience's other assets changed year-over-year?

Alto Neuroscience's other assets decreased by 40.6% year-over-year, from $569K to $338K.

What is the long-term trend for Alto Neuroscience's other assets?

Over 2 years (2023 to 2025), Alto Neuroscience's other assets has grown at a 60.6% compound annual growth rate (CAGR), from $131K to $338K.

Alto Neuroscience ANRO Other Assets

Other Assets at other companies

Wells Fargo & CompanyWFC

$86.19B-0.3%

Fifth Third BankFITB

$19.98B+61.8%

ChubbCB

$9.34B+7.3%

Realty IncomeO

$7.02B+62.4%

Truist FinancialTFC

$39.67B—

KKR & Co.KKR

$13.6B+13.8%

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$887.88M+1,358%

Enterprise value$644.49M-958%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:OtherAssets.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's other assets?: Alto Neuroscience (ANRO) reported other assets of $338K in Q1 2026.
How has Alto Neuroscience's other assets changed year-over-year?: Alto Neuroscience's other assets decreased by 40.6% year-over-year, from $569K to $338K.
What is the long-term trend for Alto Neuroscience's other assets?: Over 2 years (2023 to 2025), Alto Neuroscience's other assets has grown at a 60.6% compound annual growth rate (CAGR), from $131K to $338K.